Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Genelux (GNLX) EBITDA (2022 - 2025)

Genelux has reported EBITDA over the past 4 years, most recently at -$9.2 million for Q4 2025.

  • Quarterly results put EBITDA at -$9.2 million for Q4 2025, down 2.32% from a year ago — trailing twelve months through Dec 2025 was -$33.7 million (down 12.12% YoY), and the annual figure for FY2025 was -$32.2 million, down 7.98%.
  • EBITDA for Q4 2025 was -$9.2 million at Genelux, down from -$7.9 million in the prior quarter.
  • Over the last five years, EBITDA for GNLX hit a ceiling of $6.3 million in Q3 2022 and a floor of -$9.2 million in Q4 2025.
  • Median EBITDA over the past 4 years was -$6.6 million (2024), compared with a mean of -$5.8 million.
  • Biggest five-year swings in EBITDA: tumbled 183.65% in 2023 and later dropped 2.32% in 2025.
  • Genelux's EBITDA stood at -$3.1 million in 2022, then tumbled by 126.28% to -$7.0 million in 2023, then dropped by 29.07% to -$9.0 million in 2024, then decreased by 2.32% to -$9.2 million in 2025.
  • The last three reported values for EBITDA were -$9.2 million (Q4 2025), -$7.9 million (Q3 2025), and -$7.5 million (Q2 2025) per Business Quant data.